Affordable Insulin Now Act

Bill Number: HR 6255 | Origin Chamber: House | Status: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | Policy Area: Health

TL;DR

What

Caps monthly insulin costs at $35 or 25% of negotiated price.

Who

Rep. Angie Craig (D-MN) and several Democratic co-sponsors.

Status

Introduced in House, no House vote yet

This bill, introduced by Democratic Rep. Angie Craig of Minnesota and several co-sponsors, aims to significantly reduce the out-of-pocket costs for insulin. Starting January 1, 2026, most health plans would need to cover selected insulin products without a deductible and cap monthly cost-sharing at $35 or 25% of the negotiated price, whichever is lower. As an introduced bill, it has been referred to committees for review but has not yet been voted on by the full House.

Sponsors

Cosponsors

Where Is This Bill?

Introduced
Committee
House Vote
Senate
Law

This bill has been introduced in the House of Representatives and referred to the Committees on Energy and Commerce, Ways and Means, and Education and Workforce. It will need to pass through these committees, be voted on by the full House, then pass the Senate, and finally be signed by the President to become law.

If This Passes, You Might Notice

If this bill becomes law, starting in 2026, most health insurance plans (including individual, group, and catastrophic plans) would be required to limit your out-of-pocket cost for selected insulin products. Your plan would choose at least one version of each type of insulin (like rapid-acting or long-acting) and make it available without a deductible. For these chosen insulins, your monthly cost would be capped at the lower of $35 or 25% of the negotiated price. Any amount you pay for these specific insulins would count towards your plan's overall out-of-pocket maximum.

The Debate

Supporters Say

The bill text does not explicitly state arguments from supporters, focusing solely on legislative provisions.

Critics Say

The bill text does not explicitly state arguments from critics, focusing solely on legislative provisions.

As a legislative document, the bill text itself does not contain arguments for or against its passage. Therefore, no specific viewpoints from supporters or critics can be extracted directly from this document.